HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
The HDL hypothesis stating that simply raising HDL cholesterol (HDL-C) may produce cardiovascular benefits has been questioned recently based on several randomized clinical trials using CETP inhibitors or niacin to raise HDL-C levels. However extensive pre-clinical data support the vascular protect...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2015-09-01
|
| Seri Bilgileri: | Frontiers in Pharmacology |
| Konular: | |
| Online Erişim: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00187/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|